QDEL250117P45000
- 2.40
- 0.000.00%
QuidelOrtho Newsroom
2024's 'Biggest Loses' That Could See Reversal in 2025
Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects?
Insider Buying: QuidelOrtho President Bought US$250k Of Shares
Worst Performing Stocks for Tax Loss Selling – Wolfe
Brian Blaser Buys Handful Of Shares In QuidelOrtho
Insider Purchase: President and CEO of $QDEL (QDEL) Buys 6,033 Shares
QuidelOrtho Raised to Buy From Neutral by Citigroup
Citi Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $50
RBC Capital Sticks to Their Buy Rating for QuidelOrtho (QDEL)
QuidelOrtho Announces Appointment of Two Independent Directors to Its Board
QuidelOrtho Initiated at Hold by Jefferies
QuidelOrtho Analyst Ratings
Jefferies Initiates QuidelOrtho(QDEL.US) With Hold Rating, Announces Target Price $43
Insider Sale: 10% Owner at $QDEL (QDEL) Sells 8,260,183 Shares
QuidelOrtho Faces Strategic Shifts Amid Share Sale
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
QuidelOrtho: Goldman Sachs Acting as Sole Underwriter >QDEL
QuidelOrtho Will Not Receive Any Proceeds From Offering >QDEL
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group